Eagle Pharmaceuticals - Stock Price History | EGRX

Historical daily share price chart and data for Eagle Pharmaceuticals since 2020 adjusted for splits. The latest closing stock price for Eagle Pharmaceuticals as of September 25, 2020 is 41.61.
  • The all-time high Eagle Pharmaceuticals stock closing price was 100.56 on August 05, 2015.
  • The Eagle Pharmaceuticals 52-week high stock price is 64.94, which is 56.1% above the current share price.
  • The Eagle Pharmaceuticals 52-week low stock price is 33.80, which is 18.8% below the current share price.
  • The average Eagle Pharmaceuticals stock price for the last 52 weeks is 51.00.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Eagle Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 53.2388 40.7000 64.3100 38.6600 60.0800 49.12%
2018 62.1361 58.2100 83.8600 36.7200 40.2900 -24.58%
2017 68.0429 80.1100 96.8500 46.6200 53.4200 -32.67%
2016 58.1652 86.1500 86.1500 34.0000 79.3400 -10.52%
2015 64.3342 17.7100 100.5600 15.3500 88.6700 472.06%
2014 12.3984 12.8300 15.5000 9.3100 15.5000 0.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.560B $0.196B
Eagle Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on developing and commercializing injectable products primarily in the critical care and oncology areas in the United States. The Company markets EP-1101 to treat heparin-induced thrombocytopenia. It develops EP-3101, EP-3102, Ryanodex and EP-4104. Eagle Pharmaceuticals, Inc. is based in Woodcliff Lake, New Jersey.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $178.682B 33.53
Medtronic (MDT) Ireland $136.129B 25.64
Stryker (SYK) United States $74.576B 28.92
Boston Scientific (BSX) United States $53.107B 30.68
Lonza Group Ag (LZAGY) Switzerland $45.620B 0.00
Baxter (BAX) United States $39.840B 24.37
Terumo (TRUMY) Japan $30.003B 38.35
Zimmer Biomet Holdings (ZBH) United States $27.355B 22.70
EssilorLuxottica Societe Anonyme (ESLOY) France $27.164B 0.00
ResMed (RMD) United States $24.364B 35.32
Sunny Optical Technology (SNPTF) China $17.659B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $16.383B 0.00
Bio-Rad Laboratories (BIO) United States $14.666B 66.33
Insulet (PODD) United States $14.217B 601.53
Shandong Weigao Medical Polymer (SHWGF) China $11.080B 0.00
DiaSorin S.p.A (DSRLF) Italy $10.350B 0.00
GN STORE NORD (GNNDY) Denmark $10.221B 52.10
Quidel (QDEL) United States $8.053B 42.66
William Demant Holdings (WILYY) Denmark $7.100B 0.00
Perrigo (PRGO) Ireland $6.140B 10.54
Hill-Rom Holdings (HRC) United States $5.406B 13.42
Canopy Growth (CGC) Canada $5.305B 0.00
Haemonetics (HAE) United States $4.393B 29.27
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.250B 0.00
Neogen (NEOG) United States $3.902B 63.97
ICU Medical (ICUI) United States $3.841B 29.31
Envista Holdings (NVST) United States $3.701B 25.24
Abcam (ABCZY) $3.220B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.058B 0.00
TG Therapeutics (TGTX) United States $3.007B 0.00
National Vision Holdings (EYE) United States $2.947B 458.00
NuVasive (NUVA) United States $2.507B 34.94
Agios Pharmaceuticals (AGIO) United States $2.341B 0.00
AtriCure (ATRC) United States $1.724B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.632B 148.92
NanoString Technologies (NSTG) United States $1.620B 0.00
Cardiovascular Systems (CSII) United States $1.415B 0.00
MacroGenics (MGNX) United States $1.336B 0.00
Owens & Minor (OMI) United States $1.295B 29.01
Aphria (APHA) Canada $1.218B 0.00
InMode (INMD) Israel $1.125B 28.37
Cerus (CERS) United States $0.980B 0.00
Quanterix (QTRX) United States $0.898B 0.00
PetIQ (PETQ) United States $0.882B 25.30
BioLife Solutions (BLFS) United States $0.835B 435.00
Lantheus Holdings (LNTH) United States $0.804B 11.14
OraSure Technologies (OSUR) United States $0.762B 0.00
Phibro Animal Health (PAHC) United States $0.713B 16.32
LeMaitre Vascular (LMAT) United States $0.685B 41.80
Meridian Bioscience (VIVO) United States $0.665B 15.36
Vapotherm (VAPO) United States $0.650B 0.00
Aurora Cannabis (ACB) Canada $0.600B 0.00
Zynex (ZYXI) United States $0.553B 48.27
Omeros (OMER) United States $0.536B 0.00
Surmodics (SRDX) United States $0.517B 56.72
VAREX IMAGING (VREX) United States $0.460B 19.93
Cytosorbents (CTSO) United States $0.327B 0.00
Viemed Healthcare (VMD) United States $0.325B 11.61
HEXO (HEXO) $0.312B 0.00
Utah Medical Products (UTMD) United States $0.285B 24.44
InfuSystems Holdings (INFU) United States $0.265B 50.42
Neptune Wellness Solutions (NEPT) Canada $0.242B 0.00
Surface Oncology (SURF) United States $0.240B 0.00
Organigram Holdings (OGI) Canada $0.210B 0.00
Female Health (VERU) United States $0.184B 0.00
Chimerix (CMRX) United States $0.164B 0.00
Bovie Medical (APYX) United States $0.154B 0.00
Wound Management Technologies (SMTI) United States $0.152B 0.00
Fonar (FONR) United States $0.142B 12.58
Exagen (XGN) United States $0.137B 0.00
Liberty Health Sciences (LHSIF) United States $0.128B 0.00
Evolus (EOLS) United States $0.122B 0.00
Capricor Therapeutics (CAPR) United States $0.098B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.085B 0.00
Chembio Diagnostics (CEMI) United States $0.084B 0.00
Rockwell Medical (RMTI) United States $0.077B 0.00
United-Guardian (UG) United States $0.069B 15.39
Oramed Pharmaceuticals (ORMP) United States $0.065B 0.00
Brainsway (BWAY) Israel $0.061B 0.00
MTech Acquisition (KERN) United States $0.051B 0.00
Nephros (NEPH) United States $0.050B 0.00
Trinity Biotech (TRIB) Ireland $0.048B 9.00
ImmuCell (ICCC) United States $0.039B 0.00
FSD PHARMA INC (HUGE) Canada $0.034B 0.00
GUARDION HEALTH (GHSI) United States $0.019B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.018B 0.00
Akers Biosciences Inc (AKER) United States $0.018B 0.00
Myomo (MYO) United States $0.016B 0.00
NF Energy Saving (BIMI) China $0.016B 0.00
NeuroMetrix (NURO) United States $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00